Your browser doesn't support javascript.
loading
Comparison of the Dual Therapy of Ilaprazole-Amoxicillin and the Bismuth Quadruple Therapy of Ilaprazole-Amoxicillin-Furazolidone-Bismuth Glycyrrhizinate for Eradication of Helicobacter pylori.
Niu, Min; Zhou, Yan; Xie, Yunqian; Li, Xue; Tian, Yonggang; Yao, Li; Li, Ximei; Gao, Hengjun; Bai, Feihu.
Afiliação
  • Niu M; Department of Gastroenterology, People's Hospital of Ningxia Hui Autonomous Region, Yinchuan, China.
  • Zhou Y; Department of Gastroenterology, People's Hospital of Ningxia Hui Autonomous Region, Yinchuan, China.
  • Xie Y; School of Clinical Medicine, Ningxia Medical University, Yinchuan, China.
  • Li X; Department of Gastroenterology, The Second Affiliated Hospital of Hai Nan Medical College, Haikou, China.
  • Tian Y; Department of Gastroenterology, People's Hospital of Ningxia Hui Autonomous Region, Yinchuan, China.
  • Yao L; Department of Gastroenterology, People's Hospital of Ningxia Hui Autonomous Region, Yinchuan, China.
  • Li X; Department of Gastroenterology, People's Hospital of Ningxia Hui Autonomous Region, Yinchuan, China.
  • Gao H; Department of Gastroenterology, People's Hospital of Ningxia Hui Autonomous Region, Yinchuan, China.
  • Bai F; School of Clinical Medicine, Ningxia Medical University, Yinchuan, China.
Front Pharmacol ; 13: 771876, 2022.
Article em En | MEDLINE | ID: mdl-35571120

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Guideline Idioma: En Revista: Front Pharmacol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Guideline Idioma: En Revista: Front Pharmacol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China